Future of Drug Discovery Episode #3

In this session, Murat talks with Konrad Krawczyk, Assistant Professor SDU and Founder of NaturalAntibody. 

We will be covering Mr Natural Antibody's views on developing and using bioinformatics tools to analyse and discover biologics.

Other topics in this episode:

- Changing role of bioinformatics from assisting to being the main driver in biologics discovery
- 99% of the job is to get quality data, 1% is computational methods
- Collecting data from Patents, Scientific Publications, NGS, Therapeutics from FDA
- Developing models for binding prediction and biophysical properties
- Predictions of binding and developability, database, tool access, and expertise
- Interpretability of ML models

Antiverse - Engineering the future of drug discovery - https://www.antiverse.io/